Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Intradermal versus Intramuscular Administration of Influenza Vaccination: Rapid Review and Meta-analysis

Oluwaseun Egunsola, Fiona Clement, John Taplin, Liza Mastikhina, Joyce W. Li, Diane L. Lorenzetti, Laura E. Dowsett, Tom Noseworthy
doi: https://doi.org/10.1101/2020.10.06.20205989
Oluwaseun Egunsola
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona Clement
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fclement@ucalgary.ca
John Taplin
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liza Mastikhina
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce W. Li
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane L. Lorenzetti
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
2Health Sciences Library, University of Calgary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura E. Dowsett
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Noseworthy
1The Department Community Health Sciences, University of Calgary. Teaching Research and Wellness Building 3280 Hospital Drive NW Calgary Alberta T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Vaccinations are essential for prevention of influenza. We synthesized the published literature on the immunogenicity and safety of the influenza vaccine at reduced or full intradermal doses compared with full intramuscular doses.

Methods A rapid review of the literature was completed. MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched for studies published from 2010 until June 5th, 2020. All studies comparing intradermal and intramuscular influenza vaccinations were included. Random-effects meta-analyses of immunogenicity and safety outcomes were conducted.

Results A total of 30 relevant studies were included. Seroconversion rates were equivalent between the 3 mcg, 6 mcg, 7.5 mcg, and 9 mcg intradermal vaccine doses and the 15 mcg intramuscular vaccine dose for each of the H1N1, H3N2, and B strains, but significantly higher with the 15 mcg intradermal compared with the 15 mcg intramuscular dose, for the H1N1 (RR 1.10, 95% CI: 1.01-1.20) and B strains (RR 1.40, 95% CI: 1.13-1.73). Seroprotection rates for the 9 mcg and 15 mcg intradermal doses were equivalent with the 15 mcg intramuscular dose for all the three strains, except for the 15 mcg intradermal dose for the H1N1 strain which was significantly higher (RR 1.05, 95% CI: 1.01-1.09). Local adverse events were significantly higher with intradermal doses. Fever and chills were significantly higher with the 9 mcg intradermal dose, while all other systemic adverse events were equivalent for all doses.

Conclusion Reduced dose intradermal influenza vaccination appears to be a reasonable alternative to standard dose intramuscular vaccination because of the similarity in immunogenicity.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This Project was supported with funding from the Canadian Institutes of Health Research (CIHR) under the Drug Safety and Effectiveness Network initiative. The funders did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Contributors: TN, LED, FC, DL conceptualized the study. OE, LED, LM, JL, JT, DL acquired the data. OE analyzed the data. OE, LED, LM, JL, JT, DL drafted the article, FC and TN revised the article for critically important intellectual content. All authors approved the final version of the article.

  • Funding Statement: This Project was supported with funding from the Canadian Institutes of Health Research (CIHR) under the Drug Safety and Effectiveness Network initiative. The funders did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

  • Copyright claims/Disclaimers: The intellectual property rights in data and results generated from the work reported in this document are held in joint ownership between the MAGIC team and the named Contributors. Users are permitted to disseminate the data and results presented in this report provided that the dissemination (i) does not misrepresent the data, results, analyses or conclusions, and (ii) is consistent with academic practice, the rights of any third party publisher, and applicable laws. Any dissemination of the data and results from this document shall properly acknowledge the MAGIC team and named Contributors.

Data Availability

All datasets supporting the conclusions of this article are included within the article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted October 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Intradermal versus Intramuscular Administration of Influenza Vaccination: Rapid Review and Meta-analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Intradermal versus Intramuscular Administration of Influenza Vaccination: Rapid Review and Meta-analysis
Oluwaseun Egunsola, Fiona Clement, John Taplin, Liza Mastikhina, Joyce W. Li, Diane L. Lorenzetti, Laura E. Dowsett, Tom Noseworthy
medRxiv 2020.10.06.20205989; doi: https://doi.org/10.1101/2020.10.06.20205989
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Intradermal versus Intramuscular Administration of Influenza Vaccination: Rapid Review and Meta-analysis
Oluwaseun Egunsola, Fiona Clement, John Taplin, Liza Mastikhina, Joyce W. Li, Diane L. Lorenzetti, Laura E. Dowsett, Tom Noseworthy
medRxiv 2020.10.06.20205989; doi: https://doi.org/10.1101/2020.10.06.20205989

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5273)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5895)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (767)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (480)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2023)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)